Plan your data strategy to ensure that digital health technologies will provide high quality, compliant data that will withstand regulatory scrutiny.
Several factors have accelerated the uptake of digital health technologies (DHTs) in clinical trials, including an increased market demand in general for digital technologies, the COVID-19 pandemic, and increased acceptance of DHTs by regulators.
This white paper highlights key considerations for Sponsors and CROs as they develop their DHT strategy, including:
Offered Free by: Medidata
See All Resources from: Medidata
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.